Logo image
A Novel Hybrid CFHR1/CFH Gene Causes Atypical Hemolytic Uremic Syndrome
Journal article   Open access   Peer reviewed

A Novel Hybrid CFHR1/CFH Gene Causes Atypical Hemolytic Uremic Syndrome

Stephen J Eyler, Nicole C Meyer, Yuzhou Zhang, Xue Xiao, Carla M Nester and Richard J.H Smith
Pediatric nephrology (Berlin, West), Vol.28(11), pp.2221-2225
11/2013
DOI: 10.1007/s00467-013-2560-2
PMCID: PMC4433496
PMID: 23880784
url
http://doi.org/10.1007/s00467-013-2560-2View
Open Access

Abstract

Background Mutations in complement factor H (CFH) are associated with complement dysregulation and the development of an aggressive form of atypical hemolytic uremic syndrome (aHUS) that progresses to end-stage renal disease (ESRD) and in most patients has a high rate of recurrence following transplantation. Sequence analysis of CFH and its downstream complement factor H-related genes (CFHR1-5) reveals several macrohomologous blocks caused by large genomic duplications. This high degree of sequence identity renders this area susceptible to nonallelic homologous recombination (NAHR) events, resulting in large-scale deletions, duplications, and the generation of hybrid CFH genes. Case-Diagnosis Here, we report the finding of a novel CFHR1/CFH hybrid gene created by a de novo NAHR event in a 14-year-old girl with aHUS. The resulting fusion protein contains the first three short consensus repeats (SCRs) of CFHR1 and the terminal two SCRs of CFH. Conclusions This finding demonstrates a novel pathogenic mechanism for the development of aHUS. Additionally, since standard Sanger sequencing is unable to detect such rearrangements, all aHUS patients should receive comprehensive genetic screening that includes analysis of copy number variation in order to identify patients with poor clinical prognoses.
Atypical hemolytic uremic syndrome nonallelic homologous recombination factor H hybrid genes alternative pathway of complement

Details

Metrics

Logo image